J. Ruether

Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation.

J. Luider, J. Klassen, A. Turner, 1996, Bone marrow transplantation.

Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis

M. Coppes, S. Glück, P. Duggan, 2002, Bone Marrow Transplantation.

Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: a 10-year experience.

M. Stotts, R. Woodman, J. Russell, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome

J. Klassen, A. Turner, M. Egeler, 1999, Bone Marrow Transplantation.

Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes.

B. Andersson, H. Tran, P. Duggan, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Staging laparotomy in Hodgkin's disease: A community hospital experience

A. Jones, J. Ruether, B. Ruether, 1988, Journal of surgical oncology.

Partially mismatched blood cell transplants for high-risk hematologic malignancy

J. Luider, J. Klassen, A. Turner, 1997, Bone Marrow Transplantation.

Second allogeneic transplants for leukemia using blood instead of bone marrow as a source of hemopoietic cells.

M. Coppes, J. Luider, J. Klassen, 1996, Bone marrow transplantation.